Research Square
The AIMSI protocol: study protocol of a randomized, double-blind, non-inferiority clinical trial in dermocosmetics dedicated to atopic dermatitis (Lipikar®, La Roche-Posay vs. Relipid®, NEUTRADERM)
By L’Orphelin J, Briant A, Garderes J and 6 others.
Abstract
Abstract (171/350 words)
Background
Severe and mild atopic dermatitis is classically treated with topical, i.e., moisturizer and topical steroids. The environment is competitive and dermatologists’precriptions are guided more by habit than evidence based-medicine.
